References
Stagi S, Gulino AV, Lapi E, Rigante D. Epigenetic control of the immune system: a lesson from Kabuki syndrome. Immunol Res. 2016;64(2):345–59.
Lin J, Lee W, Huang J, Chen PK, Chan K, Lo L, et al. Immunologic assessment and KMT2D mutation detection in Kabuki syndrome. Clin Genet. 2015;88(3):255–60.
Smedley D, Robinson PN. Phenotype-driven strategies for exome prioritization of human Mendelian disease genes. Genome Med. 2015;7(1):81.
Paulussen ADC, Stegmann APA, Blok MJ, Tserpelis D, Posma-Velter C, Detisch Y, et al. MLL2 mutation spectrum in 45 patients with Kabuki syndrome. Hum Mutat. 2011;32(2):E2018–25.
Lo B, Fritz JM, Su HC, Uzel G, Jordan MB, Lenardo MJ. CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency. Blood. 2016;128(8):1037–42.
Acknowledgements
The authors acknowledge Benedicte Néven (Necker Hospital, Paris), Elda Del Giudice, Alberta Leon (Research & Innovation Srl), Irene Toldo, Clementina Boniver, Ignazio D’Errico, Giuseppe Basso, Maria Gabelli, and Marina Paola Gardiman (Azienda Ospedaliera di Padova) for their contribution to the management of the patient.
Funding
The work was funded by a grant from the Fondazione Città della Speranza ONLUS (thanks to the initiative “Gusto per la Ricerca”) and a grant from the Associazione Italiana contro le Leucemia-Linfomi e Mieloma ONLUS, Sezione della Provincia di Padova.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Online Resource 1
(DOCX 16 kb)
Online Resource 2
(DOCX 209 kb)
Rights and permissions
About this article
Cite this article
Marzollo, A., Colavito, D., Sartori, S. et al. Cerebral Lymphoproliferation in a Patient with Kabuki Syndrome. J Clin Immunol 38, 475–477 (2018). https://doi.org/10.1007/s10875-018-0516-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-018-0516-9